Application of selected reaction monitoring and parallel reaction monitoring for investigation of HL-60 cell line differentiation

Abstract

Targeted mass spectrometry represents a powerful tool for investigation of biological processes. The convenient approach of selected reaction monitoring using stable isotope-labeled peptide standard (SIS) is widely applied for protein quantification. Along with this method, high-resolution parallel reaction monitoring has been increasingly used for protein targeted analysis. Here we applied two targeted approaches (selected reaction monitoring with SIS and label-free parallel reaction monitoring) to investigate expression of 11 proteins during all-trans retinoic acid-induced differentiation of HL-60 cells. In our experiments, we have determined the proteins expression ratio at 3, 24, 48, and 96 h after all-trans retinoic acid treatment in comparison with 0 h, respectively. Expression profiles of four proteins (VAV1, PRAM1, LYN, and CEBPB) were highly correlated (r > 0.75) and FGR expression was detected on proteome level starting from 24 h by both techniques. For prominent differences (fold change ≥ 2) label-free parallel reaction monitoring is not inferior to selected reaction monitoring with isotopically labeled peptide standards. Differentially expressed proteins, that have been determined in our study, can be considered as potential drug targets for acute myeloid leukemia (AML) treatment.

Keywords

Selected reaction monitoring parallel reaction monitoring all-trans retinoic acid HL-60 cell line time-course study

Get full access to this article

View all access options for this article.

References

Kopylov

Ilgisonis

Moysa

et al.

Targeted quantitative screening of chromosome 18 encoded proteome in plasma samples of astronaut candidates. J Proteome Res 2016; 15: 4039–4046.

Carr

Abbatiello

Ackermann

et al.

Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach. Mol Cell Proteomics 2014; 13: 907–917.

Bilan

Selevsek

Kistemaker

HAV

et al.

New quantitative mass spectrometry approaches reveal different ADP-ribosylation phases dependent on the levels of oxidative stress. Mol Cell Proteomics 2017; 16: 949–958.

Morales Betanzos

Federspiel

Palubinsky

et al.

Dynamic phosphorylation of apoptosis signal regulating kinase 1 (ASK1) in response to oxidative and electrophilic stress. Chem Res Toxicol 2016; 29: 2175–2183.

Zhao Y and Brasier AR. Qualification and Verification of Protein Biomarker Candidates. Adv Exp Med Biol 2016; 919: 493–514.

Rahman

SMJ

Zimmerman

et al.

The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer. JCI Insight 2016; 1: e88814.

Vandenbrouck

Lane

Carapito

et al.

Looking for missing proteins in the proteome of human spermatozoa: an update. J Proteome Res 2016; 15: 3998–4019.

Edfors

Danielsson

Hallström

et al.

Gene-specific correlation of RNA and protein levels in human cells and tissues. Mol Syst Biol 2016; 12: 883.

Hood

Fuentes

Patel

et al.

Fast conventional Fmoc solid-phase peptide synthesis with HCTU. J Pept Sci 2008; 14: 97–101.

10.

Fekkes

. State-of-the-art of high-performance liquid chromatographic analysis of amino acids in physiological samples. J Chromatogr B Biomed Appl 1996; 682: 3–22.

11.

Wiśniewski

Zougman

Nagaraj

et al.

Universal sample preparation method for proteome analysis. Nat Methods 2009; 6: 359–362.

12.

Sacha

Zawada

Hartwich

et al.

The effect of β-carotene and its derivatives on cytotoxicity, differentiation, proliferative potential and apoptosis on the three human acute leukemia cell lines: U-937, HL-60 and TF-1. Biochim Biophys Acta 2005; 1740: 206–214.

13.

Hedblom

Laursen

Miftakhova

et al.

CDK1 interacts with RARγ and plays an important role in treatment response of acute myeloid leukemia. Cell Cycle 2013; 12: 1251–1266.

14.

Bertagnolo

Grassilli

Bavelloni

et al.

Vav1 modulates protein expression during ATRA-induced maturation of APL-derived promyelocytes: a proteomic-based analysis. J Proteome Res 2008; 7: 3729–3736.

15.

Denis

Benecke

Di Gioia

et al.

PRAM-1 potentiates arsenic trioxide-induced JNK activation. J Biol Chem 2005; 280: 9043–9048.

16.

Moog-Lutz

Peterson

Lutz

et al.

PRAM-1 is a novel adaptor protein regulated by retinoic acid (RA) and promyelocytic leukemia (PML)-RA receptor alpha in acute promyelocytic leukemia cells. J Biol Chem 2001; 276: 22375–22381.

17.

Katagiri

Yokoyama

Yamamoto

et al.

Lyn and Fgr protein-tyrosine kinases prevent apoptosis during retinoic acid-induced granulocytic differentiation of HL-60 cells. J Biol Chem 1996; 271: 11557–11562.

18.

Studzinski

. Retinoblastoma protein and CCAAT/enhancer-binding protein beta are required for 1,25-dihydroxyvitamin D3-induced monocytic differentiation of HL60 cells. Cancer Res 2004; 64: 370–377.

19.

Strudwick

Borden

KLB

. Finding a role for PML in APL pathogenesis: a critical assessment of potential PML activities. Leukemia 2002; 16: 1906–1917.

20.

Pierantoni

Agosti

Fedele

et al.

High-mobility group A1 proteins are overexpressed in human leukaemias. Biochem J 2003; 372: 145–150.

21.

Zhang

Wang

Chen

et al.

Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells. J Biosci 2000; 25: 275–284.

22.

Moog-Lutz

Peterson

Lutz

et al.

PRAM-1 is a novel adaptor protein regulated by retinoic acid (RA) and promyelocytic leukemia (PML)-RA receptor in acute promyelocytic leukemia cells. J Biol Chem 2001; 276: 22375–22381.

23.

Marcinkowska

Garay

Gocek

et al.

Regulation of C/EBPbeta isoforms by MAPK pathways in HL-60 cells induced to differentiate by 1,25-dihydroxyvitamin D3. Exp Cell Res 2006; 312: 2054–2065.